Is this stem cell therapy?

We do not describe or market this as stem cell therapy. Birth-tissue–derived products are discussed for what they are, and any conversation about them happens after an evaluation rather than as an advertised outcome.

These products are not FDA-approved for the treatment of orthopedic or musculoskeletal conditions. That is part of the conversation we have with any patient for whom this option is considered.

How do you decide whether this is appropriate for me?

Through an evaluation. We review your history, examine you, look at any relevant imaging or laboratory information, and discuss your goals. Only then do we talk about whether this option — or any option — makes sense for your situation.

Is this covered by insurance?

Most of the services in this category are not covered by insurance. We discuss cost openly before anything is scheduled, so you can make an informed decision.

What happens if this isn't the right fit for me?

We tell you. If your findings point toward a different approach — including care outside this practice — we say so and help direct you to the appropriate provider.

← All treatments

Umbilical Cord / Wharton's Jelly

Q: What is Wharton's Jelly?

Wharton's Jelly is the gelatinous connective tissue inside the human umbilical cord. Products derived from donated birth tissue are prepared by regulated suppliers and, when appropriate, may be discussed as part of an individualized plan.

An Advanced Regenerative Option — When Appropriate

At Regenerative Medicine of Raynham, we don't begin with a product or procedure. We begin with an evaluation.

For appropriately selected patients, umbilical cord/Wharton's Jelly-derived products may be among the regenerative options discussed as part of an individualized care plan.

Request an Evaluation (774) 409-5055

Serving Raynham, MA and Southeastern Massachusetts.

Wharton's Jelly is the connective tissue found within the human umbilical cord. At Regenerative Medicine of Raynham, umbilical cord–derived products are considered only for appropriately selected patients, after an individualized evaluation of your history, examination findings and goals. These products are not FDA-approved for orthopedic conditions, and they are discussed as one possible component of a broader plan — never as a standalone promise.

What Is Wharton's Jelly?

Wharton's Jelly is the connective tissue found within the human umbilical cord. Its natural biological composition has made umbilical-cord tissue and its components an area of considerable interest in regenerative-medicine research.

Products derived from donated birth tissue vary significantly in their processing, composition, intended use and regulatory status. They should therefore not be assumed to be equivalent products.

Why Is It Used in Our Practice?

Our interest in regenerative approaches is based on supporting the body's natural biological environment and recovery processes — not promising to replace damaged tissue or cure a disease.

When appropriate, a regenerative product may be considered as one component of a broader plan that can also address inflammation, movement, strength, mechanical stress and other factors that may influence recovery.

What About Exosomes?

Exosomes are small extracellular vesicles involved in cell-to-cell communication and are an active area of biomedical research.

Some regenerative products are marketed using terms such as exosomes, extracellular vesicles or secretome. These terms should not be assumed to mean the same thing, and product composition can vary.

Importantly, there are currently no FDA-approved exosome products. For that reason, we do not present exosomes as an FDA-approved treatment for joint pain or other orthopedic conditions.

Evaluation Before Recommendation

Not every patient is an appropriate candidate for every procedure.

Recommendations are based on the patient's history, examination findings, goals, available diagnostic information and consideration of reasonable alternatives.

When another type of care or referral is more appropriate, that should be part of the conversation as well.

Our Approach

1
Control Inflammation
2
Support Recovery
3
Restore Function

A regenerative product is one component of a broader plan — not the plan itself.

How we evaluate patients

Ready to Learn More?

If you're interested in learning whether regenerative options may be appropriate for your situation, the first step is an individualized evaluation.

We don't begin with a procedure. We begin with understanding you.

Request an Evaluation (774) 409-5055

Regenerative Medicine of Raynham
575 South Street West, STE 2B
Raynham, MA 02767
(774) 409-5055

Concerns this is commonly evaluated for

Being listed here does not mean this option is appropriate for your case. It means these are the concerns where we most often consider it during an evaluation.

Answers

Umbilical Cord / Wharton's Jelly questions we hear most

Straight answers to what patients ask before their first visit. Don't see yours? Call us — we're happy to talk it through.

Important Information

Umbilical cord/Wharton's Jelly-derived regenerative medicine products offered for orthopedic or musculoskeletal uses are not FDA-approved to diagnose, treat, cure or prevent orthopedic diseases or conditions. FDA states that regenerative medicine therapies have not been approved for orthopedic conditions including osteoarthritis, tendonitis, disc disease, back pain, hip pain, knee pain, neck pain or shoulder pain. There are currently no FDA-approved exosome products.

Information on this website is provided for general educational purposes and should not be interpreted as a guarantee of safety, effectiveness, tissue regeneration or a particular clinical outcome. Individual results vary. An evaluation is required to determine what options, if any, may be appropriate for an individual patient.

Provided at Regenerative Medicine of Raynham by Dr. Brian Petrie, DC, with medical oversight by Dr. David Cunningham, MD. Meet our team. Page last reviewed August 18, 2026.